Exome Sequencing Implicates DGKZ, ESRRA, and GXYLT1 for Modulating Granuloma Formation in Crohn’s Disease, September 2023 JPGN

Exome Sequencing Implicates DGKZ, ESRRA, and GXYLT1 for Modulating Granuloma Formation in Crohn’s Disease, September 2023 JPGN

Key:

Complete
Failed
Available
Locked
CME Requirements and Learning Objectives: Exome Sequencing Implicates DGKZ, ESRRA, and GXYLT1 for Modulating Granuloma Formation in Crohn’s Disease, September 2023 JPGN
Open to download resource.
Open to download resource.
You must register to access.
Exome Sequencing Implicates DGKZ, ESRRA, and GXYLT1 for Modulating Granuloma Formation in Crohn’s Disease, September 2023 JPGN
Open to download resource.
Open to download resource.
You must register to access.
Post-Test: Exome Sequencing Implicates DGKZ, ESRRA, and GXYLT1 for Modulating Granuloma Formation in Crohn’s Disease, September 2023 JPGN
3 Questions  |  Unlimited attempts  |  2/3 points to pass
3 Questions  |  Unlimited attempts  |  2/3 points to pass
You must register to access.
Post-Webinar Evaluation: Exome Sequencing Implicates DGKZ, ESRRA, and GXYLT1 for Modulating Granuloma Formation in Crohn’s Disease, September 2023 JPGN
14 Questions
14 Questions Post-Webinar Evaluation: Exome Sequencing Implicates DGKZ, ESRRA, and GXYLT1 for Modulating Granuloma Formation in Crohn’s Disease, September 2023 JPGN
You must register to access.
Certificate: Exome Sequencing Implicates DGKZ, ESRRA, and GXYLT1 for Modulating Granuloma Formation in Crohn’s Disease, September 2023 JPGN
1.00 credit  |  Certificate available
1.00 credit  |  Certificate available
You must register to access.